InflaRx (IFRX) Property, Plant & Equipment (Net) (2017 - 2026)
InflaRx (IFRX) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
64,489.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
116.30 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
8,690.00 |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1.61 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
2.09 Mn |
| 10 |
InflaRx |
752.21 Mn |
752.21 Mn |
10,877.40 |
326,374.62 |
| Date | Value |
|---|
| Mar 31, 2026 |
326,374.62 |
| Mar 31, 2026 |
326,374.62 |
| Dec 31, 2025 |
336,777.58 |
| Dec 31, 2025 |
336,777.58 |
| Sep 30, 2025 |
362,047.01 |
| Sep 30, 2025 |
362,047.01 |
| Jun 30, 2025 |
279,624.61 |
| Jun 30, 2025 |
279,624.61 |
| Mar 31, 2025 |
259,370.51 |
| Mar 31, 2025 |
259,370.51 |
| Dec 31, 2024 |
273,859.63 |
| Dec 31, 2024 |
273,859.63 |
| Sep 30, 2024 |
285,800.64 |
| Sep 30, 2024 |
285,800.64 |
| Jun 30, 2024 |
293,393.71 |
| Jun 30, 2024 |
293,393.71 |
| Mar 31, 2024 |
308,573.46 |
| Mar 31, 2024 |
308,573.46 |
| Dec 31, 2023 |
311,567.45 |
| Dec 31, 2023 |
311,567.45 |
